Sentences with phrase «slower cognitive development»

Physical punishment is associated with a range of mental health problems in children, youth and adults, including depression, unhappiness, anxiety, feelings of hopelessness, use of drugs and alcohol, and general psychological maladjustment.26 — 29 These relationships may be mediated by disruptions in parent — child attachment resulting from pain inflicted by a caregiver, 30,31 by increased levels of cortisol32 or by chemical disruption of the brain's mechanism for regulating stress.33 Researchers are also finding that physical punishment is linked to slower cognitive development and adversely affects academic achievement.34 These findings come from large longitudinal studies that control for a wide range of potential confounders.35 Intriguing results are now emerging from neuroimaging studies, which suggest that physical punishment may reduce the volume of the brain's grey matter in areas associated with performance on the Wechsler Adult Intelligence Scale, third edition (WAIS - III).36 In addition, physical punishment can cause alterations in the dopaminergic regions associated with vulnerability to the abuse of drugs and alcohol.37
[7] Exposure to arsenic can result in insulin resistance, immune system suppression, slowed cognitive development, cardiovascular damage, and weight gain / loss.
Previous studies have shown that maternal depression has a negative effect on young hearing children, slowing their cognitive development and predicting behavioral problems.

Not exact matches

We're slowing getting to the point of recognizing the vital importance of parents in the early childhood years, that social - emotional development affects cognitive gain, too, that spanking and physical punishments are archaic and unneeded.
What slowed the infants» cognitive or physical development were changing conditions — a mother who swung from depressed before birth to healthy afterward or vice versa.
One of the main challenges in finding a treatment for the disease in the future is the research and development of pharmacological therapies capable of activating the Crtc1 protein, with the aim of preventing, slowing down or reverting cognitive alterations in patients.
The operationalization of mild cognitive impairment (MCI) led to targeting earlier symptomatic cases of the illness and treatment strategies based less on pathology and more on a chance to halt or slow decline than there would be earlier in the disease.1 With the development of amyloid imaging, MCI due to AD diagnosis was refined, 2 and early - stage AD was extended further to include preclinical AD, 3 wherein a positive amyloid positron emission tomography (PET) scan or diagnostic low levels of cerebrospinal fluid β - amyloid (Aβ) indicated the presence of pathology in people who were cognitively normal.
In a development that highlights the potential to mitigate brain diseases (such as Schizophrenia) via gene therapy, The University of California, San Diego (UCSD) announced today that Alzheimer's Cognitive Decline Slowed In Gene Therapy Patients.
a b c d e f g h i j k l m n o p q r s t u v w x y z